Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Obesity gene found in Labradors and humans
 
Researchers say the findings demonstrates how non-traditional animal models could be used to study complex diseases.

The gene could support obesity research across species.

A genetic study into Labrador retrievers has revealed an obesity-related gene which could also influence obesity in humans.

The research team, from the University of Cambridge, suggest that this genetic link between Labrador retrievers and humans could provide a useful target for obesity research in both species.

Although it is influenced by biological and environmental factors, obesity is generally considered to be a heritable condition. However the research team says that, despite 40-60 per cent of pet dogs being diagnosed with obesity, the genetic basis of canine obesity is poorly understood.

In human research, despite numerous genetic loci being identified, the mechanisms behind the associations are considered challenging.

The genetic link between dogs and humans was identified during a genome-wide association study of 241 Labrador retrievers. Labrador retrievers are considered to be particularly prone to obesity, believed to be due to complex inheritance patterns.

With a cross-species approach, researchers identified five genes that were linked to obesity in both dogs and humans. DENND1B demonstrated the strongest genetic association.

The gene affects the brain pathway responsible for regulating energy balance and appetite. This in turn influences body condition score (BCS) as well as body weight.

DENND1B was found to be highly conserved across both species, with strong similarities found between the gene in Labrador retrievers and the gene in humans.

Previous research into DENND1B in humans had found links between the gene variants and body mass index. Researchers also identified a rare and harmful mutation which appeared to disrupt energy regulation in a human with severe obesity.

However, in dogs, the risk for obesity was also found to be influenced in part by eating behaviour. Researchers say that this highlights the significance of gene-environment interactions, reinforcing human studies linking food abundance and heightened appetite to increased obesity risk.

The research team says that the findings of their project not only reveal the gene’s potential as a cross-species research target, but also highlight how non-traditional animal models could be used to study complex diseases.

Dr Alyce McClellan, of the University of Cambridge, said: “These genes are not immediately obvious targets for weight-loss drugs, because they control many other key biological processes in the body that should not be interfered with.

"Nevertheless, the results emphasise the importance of fundamental brain pathways in controlling appetite and body weight,”

The full study can be found in the journal Science.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.